Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Phantom- and simulation-based validation of combined diffusion relaxometry in ex vivo ADRD white matter.
β-oxidation-mediated differentiation of effector CD4 T cells in the lung enhances neuroinflammation.
Astrocyte Heterogeneity in Multiple Sclerosis From Reactive Glia to Therapeutic Targets.
Statin Therapy Protects White Matter in Cerebral Small Vessel Disease Independent of Lipid-Lowering: Biomarker and Neuroimaging Evidence.
Percutaneous spinal stimulation to enhance gait and alleviate functional impairments in multiple sclerosis: A pilot study.
Peripheral complement C4 protein in schizophrenia: Association with gene copy number and immune cell subtypes.
Novel insights into early Alzheimer's disease: quantitative gradient recalled echo MRI reveals preatrophic neuronal and myelin injury concurrent with emerging amyloid pathology.
Pediatric Guillain-Barré Syndrome.
PRIMUS: a precision medicine platform reusing clinical trials and registry data to support treatment selection in multiple sclerosis.
GV1001: repurposing a telomerase-derived peptide for neurological therapeutics.
Combined internal neurolysis and targeted proximal trigeminal root glycerol delivery for refractory multiple sclerosis-related trigeminal neuralgia: a case report.
Fixational Microsaccades in Patients With Parkinson Disease.
A tailored cognitive behavioural therapy intervention for depression in those newly diagnosed with multiple sclerosis (ACTION-MS): A randomised, assessor-blinded, active comparator trial.
Nasal-Predominant Ganglion Cell-Inner Plexiform Layer Thinning Distinguishes Early-Stage Leber Hereditary Optic Neuropathy From Acute Optic Neuritis.
Discrepancy between subjective and objective cognitive function in multiple sclerosis and association with mood, fatigue, and pain.
[What do we know about compassion focused therapy for anxiety and depressive symptoms: A scoping review].
Does depressed mood affect accuracy of perceptions of cognitive function in multiple sclerosis? The role of momentary depressive symptoms in the correspondence between subjective and objective cognition in multiple sclerosis.
Evaluation of Documented Infections by Provider Specialty in Patients with Multiple Sclerosis Receiving Disease-Modifying Therapies: A Claims Database Analysis.
French NOMADMUS Cohort Overview: Landscape Evolution of AQP4+NMOSD and MOGAD From 2010 to 2024.
Ofatumumab therapy modulates the meningeal lymphatic draining function in patients with multiple sclerosis: a pilot study.
SNAP-23 mediated vesicular trafficking in oligodendrocytes is necessary to maintain adult myelin integrity in mice.
Learning Beyond the Clinic: Can Point of Choice Visual Feedback Prompts Elicit Motor Behavior Changes in Persons with Multiple Sclerosis?
Association Between Multiple Sclerosis Severity and Functional Variants in Key Antioxidant Defense and Ferroptosis-Related Genes.
Six-Month Visual Outcomes in Pediatric Optic Neuritis: A Multicenter Study From South Korea.
Seronegative Chronic Relapsing Inflammatory Optic Neuropathy.
Pages
« first
‹ previous
…
993
994
995
996
997
998
999
1000
1001
…
next ›
last »